Kupryjańczyk, J., Szymańska, T., Mądry, R., Timorek, A., Stelmachów, J., Karpińska, G., . . . Markowska, J. (2003). Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen. Nature Publishing Group.
Citação norma ChicagoKupryjańczyk, J., et al. Evaluation of Clinical Significance of TP53, BCL-2, BAX and MEK1 Expression in 229 Ovarian Carcinomas Treated With Platinum-based Regimen. Nature Publishing Group, 2003.
Citação norma MLAKupryjańczyk, J., et al. Evaluation of Clinical Significance of TP53, BCL-2, BAX and MEK1 Expression in 229 Ovarian Carcinomas Treated With Platinum-based Regimen. Nature Publishing Group, 2003.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.